Delivery Order SPE2DB20D3303-SPE2DB23FA1FU

Award Date 9/7/23
Potential Completion Date 9/8/23
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $30,554.13 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Amerisourcebergen will deliver the Lupron Depot kits to its facility in Conshohocken, Pennsylvania, fulfilling the order between August 16-17, 2023. As the DLA supports military treatment...
The Defense Logistics Agency awarded a $9,820 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg kits to be delivered over a one day period ending June 22, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its corporate office located in Conshohocken, Pennsylvania. As a key supplier of pharmaceuticals to the Department of Defense, this order for Lupron Depot, a drug used to treat prostate cancer and...
The Defense Logistics Agency awarded a $40,252 delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal customers. Amerisourcebergen will deliver the Lupron Depot kits from its facility in Conshohocken, Pennsylvania to an unknown customer by September 14, 2023, with performance starting on...
The Defense Logistics Agency awarded a $4,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal customers. Amerisourcebergen will deliver the Lupron Depot kits to its Conshohocken, Pennsylvania facility by September 15, 2023 to support the DLA's medical supply needs. No subcontractors or...
The Defense Logistics Agency awarded a $16,947 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the Lupron Depot kits to its facility in Conshohocken, Pennsylvania by August 8, 2023 to support DLA's medical supply needs. No subcontractors or set aside...
The Defense Logistics Agency awarded a $8,143.32 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal customers. Amerisourcebergen will deliver the Lupron Depot kits to its facility located in Conshohocken, Pennsylvania by the period of performance end date of August 21, 2023. No...
The Defense Logistics Agency awarded a $5,854 delivery order contract to Amerisourcebergen Drug Corporation for Lupron Depot 3.75 mg kits. As part of its pharmaceutical supply chain management responsibilities, DLA issued the firm fixed price order under an existing Prime Vendor contract vehicle. Amerisourcebergen will deliver the drug kits to a facility in Conshohocken, Pennsylvania by July 7, 2023 to support DOD medical readiness programs. No set aside designation or subcontractors were...
The Defense Logistics Agency awarded a $7,904.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 3.75 mg kits. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 3, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award information. The delivery order was issued against an existing...
The Defense Logistics Agency awarded a $46,470.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order is associated with DLA's prime vendor program and supports the agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from June 22 to June 23, 2023. No subcontractors or set aside designations were identified. The award draws from DLA's budget...
The Defense Logistics Agency awarded a $31,189.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 8, 2023. No subcontractors or set aside designations were identified. This order...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB23FA1FU
    Delivery Order

The Defense Logistics Agency awarded a $2,887.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 3.75 mg kits. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal customers. Amerisourcebergen will deliver the Lupron Depot kits from its facility in Conshohocken, Pennsylvania by September 8, 2023 to support DLA's medical supply needs. No subcontractors or set aside designations were identified. The order provides a critical drug for treating prostate cancer and endometriosis patients under DLA's procurement programs.

Generated 12/23/23, 2:22 PM